The DOI matches its Crossref record.
Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial
Open accessAbstract
A total of 610 patients with small cell lung cancer were entered into a randomised trial designed to assess the effect of duration of initial chemotherapy on survival. Patients were randomised to receive either four or eight courses of cytotoxic chemotherapy with cyclophosphamide, vincristine and etoposide and also randomised to receive, on disease progression, either second line chemotherapy (methotrexate and doxorubicin) or symptomatic treatment only. In the whole study 196 (32.1%) had limited disease and 414 (67.9%) extensive disease. During initial chemotherapy the response rate (complete and partial responses) after four courses of treatment was 61% with no significant increase in patients receiving eight courses (63%). In those randomised to receive relapse chemotherapy the response rate was improved slightly for those who had originally received four courses of chemotherapy (25.6%) over those receiving eight (18.7%). The overall results show that of the four possible treatment randomizations, four courses of chemotherapy alone is inferior in terms of overall survival (30 weeks median survival) to the other three treatment options (39 weeks median survival, P less than 0.01). In patients responding to initial chemotherapy the disadvantage of four courses of chemotherapy alone was apparent (median survival of 40 weeks versus 49 weeks, P = 0.003) but not if drug treatment was given on relapse. The study shows that limiting treatment to four courses of chemotherapy alone is associated with inferior survival, but this is not the case if chemotherapy is given at relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
O'Brien, M. E. R., Ciuleanu, T.-E., Tsekov, H., Shparyk, Y., Čučeviá, B., Juhasz, G., Thatcher, N., Ross, G. A., Dane, G. C., & Crofts, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5821 · Cited by 649
Sher, T., Dy, G. K., & Adjei, A. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.3.355 · Cited by 498
Wood, A. J. J., & Ihde, D. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272006 · Cited by 428
Treatment of Small Cell Lung Cancer
Jett, J. R., Schild, S. E., Kesler, K. A., & Kalemkerian, G. P. (2013) · Chest · doi:10.1378/chest.12-2363 · Cited by 354
Schiller, J. H., Adak, S., Cella, D., DeVore, R. F., & Johnson, D. H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2114 · Cited by 294
Metadata
- Authors
- Spiro, S., Souhami, R., Geddes, D., Ash, C., Quinn, H., Harper, P., Tobias, J., Partridge, M., & Eraut, D.
- Venue
- British Journal of Cancer
- Published
- 1989-04
- Volume
- 59
- Issue
- 4
- Pages
- 578-583
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2059422367
- Cited by
- 174
- References
- 0
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. https://app.cochat.ai/papers/10.1038/bjc.1989.117
- The paper
- Spiro, S., Souhami, R., Geddes, D., Ash, C., Quinn, H., Harper, P., Tobias, J., Partridge, M., & Eraut, D. (1989). Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. British Journal of Cancer. https://doi.org/10.1038/bjc.1989.117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.